In November HFPN hosted its inaugural policy summit. The event framed heart failure alongside major policy debates, showcased change leaders in heart failure policy, and highlighted priority topics for heart failure care in 2021 and beyond.
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .